Marketing and Distribution

• Countries served directly by in-house commercial operations currently represent over 80% of the Company’s yearly product sales revenues.
• Valneva’s commercial teams work continuously to improve service and performance, including embracing digital technology, which allows to better connect with travelers, physicians and other health care professionals.
• Valneva puts the customer at the heart of its activities and focuses on their needs for improved awareness, a deeper understanding of the travel health landscape, and tailor-made services to achieve their objectives.
• Valneva continues to leverage its commercial organization to distribute third-party products and aims to attract additional products to further leverage its commercial infrastructure. Through its partnership with Seqirus, Valneva commercializes two differentiated flu vaccines in Austria. Valneva entered into a marketing and distribution partnership with Bavarian Nordic in 2020 to commercialize their Rabipur^® and Encepur^® brands in Austria, the UK, France, Belgium, The Netherlands, Luxembourg and Canada. In 2022, Valneva and VBI Vaccines Inc. announced a partnership in select European markets for the marketing and distribution of PreHevbri®.

Select your country to learn more:

• Valneva Austria
• Valneva Canada
• Valneva France
• Valneva Nordic
• Valneva UK
• Valneva U.S.